/logo.svgIpoTec


Accretion Pharmaceuticals Ipo


Objects of the Issue

  • Capital expenditure towards purchase of new equipment/ machineries, etc.

  • Capital expenditure towards upgradation of existing manufacturing facility

  • Repayment/prepayme nt of certain borrowings availed by the Company

  • Funding working capital requirements

  • General Corporate Purpose

Accretion Pharmaceuticals IPO Review

  • Canara Bank –

  • DRChoksey FinServ –

  • Emkay Global –

  • Hem Securities –

  • IDBI Capital –

  • Marwadi Shares –

  • Nirmal Bang –

  • SBICAP Securities –

  • Sharekhan –

  • SMC Global –

  • Sushil Finance –

  • Swastika Investmart –

  • Ventura Securities –

  • Geojit –

  • Reliance Securities –

  • Capital Market –

  • BP Wealth –

  • ICICIdirect –

  • Choice Broking –

IPO Lead Managers aka Merchant Bankers

  • Jawa Capital Services Private Limited

ApplicationLot SizeSharesAmount
Retail Minimum11200₹1,21,200
Retail Maximum11200₹1,21,200
S-HNI Minimum22,400₹2,42,400

IPO Open Date:May 14, 2025
IPO Close Date:May 16, 2025
Basis of Allotment:May 19, 2025
Refunds:May 20, 2025
Credit to Demat Account:May 20, 2025
IPO Listing Date:May 21, 2025

Period EndedRevenueExpenseProfit After TaxAssets
2022₹22.58₹783.90₹0.08₹17.74
2023₹29.53₹1472.25₹0.10₹20.58
2024₹33.94₹2883.26₹3.88₹27.05
July 2024₹11.89₹1423.72₹1.57₹29.34

KPIValues
ROE:72.80%
ROCE:36.73%
EBITDA Margin:23.06%
PAT Margin:11.51%
Debt to equity ratio:2.52
Earning Per Share (EPS):₹9.69 (Basic)
Price/Earning P/E Ratio:N/A
Return on Net Worth (RoNW):72.47%
Net Asset Value (NAV):₹-

CompanyEPSPE RatioRoNW %NAVIncome
Sakar Healthcare Limited5.6465.304.45%120.65– Cr.
Lincoln PharmaceuticalsLimited46.5812.5815.74%295.98– Cr.
Sotac PharmaceuticalsLimited5.2423.0911.91%43.69– Cr.

IPO Open Date:May 14, 2025
IPO Close Date:May 16, 2025
Face Value:₹10 Per Equity Share
IPO Price Band:₹96 to ₹101 Per Share
Issue Size:Approx ₹29.75 Crores
Fresh Issue:Approx ₹29.75 Crores
Issue Type: Book Built Issue
IPO Listing:NSE SME
Retail Quota:Not more than 35%
QIB Quota:Not more than 50%
NII Quota:Not more than 15%
DRHP Draft Prospectus:Click Here
RHP Draft Prospectus:Click Here
Anchor Investors List:Click Here

Disclaimer:Logos and other registered trademarks of funds used on this platform are held by their respective owners. IpoTec does not claim ownership or association on them, and their use is purely for informational and illustrative purposes.

Copyrights ©2025 IpoTec. All rights reserved.